- Home
- VCV vs ANGO Comparison
VCV vs ANGO Comparison
Compare VCV & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$10.34
Company Overview
Basic Information| Metric | VCV | ANGO |
|---|---|---|
| Founded | N/A | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 537.8M | 439.8M |
| IPO Year | 1994 | 2004 |
Fundamental Metrics
Financial Performance| Metric | VCV | ANGO |
|---|---|---|
| Price | $10.74 | $10.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $19.33 |
| AVG Volume (30 Days) | 87.0K | ★ 234.4K |
| Earning Date | 01-01-0001 | 04-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.92 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $291,010,000.00 |
| Revenue This Year | N/A | $9.11 |
| Revenue Next Year | N/A | $4.94 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.17 |
| 52 Week Low | $9.51 | $8.36 |
| 52 Week High | $11.38 | $13.99 |
Technical Indicators
Market Signals| Indicator | VCV | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 27.19 | 38.54 |
| Support Level | $10.52 | $9.73 |
| Resistance Level | $10.73 | $11.06 |
| Average True Range (ATR) | 0.10 | 0.34 |
| MACD | -0.03 | -0.06 |
| Stochastic Oscillator | 8.49 | 4.47 |
Price Performance
Historical Comparison VCV
ANGO
About VCV Invesco California Value Municipal Income Trust
Invesco California Value Municipal Income Trust is engaged in the field of financial services. Its objective is to seek to provide common shareholders with a high level of current income exempt from federal and California income taxes, consistent with preservation of capital.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.